Source: Annual Congress 2011 - Asthma management and response
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Malagrinò, F. Costa, L. Melosini, A. Di Franco, G. Catapano, P. Paggiaro (Pisa, Italy). Montelukast as add-on therapy may improve some indices of small airways involvement in uncontrolled asthmatics. Eur Respir J 2011; 38: Suppl. 55, 3952

Member's Comments

No comment yet.

Related content which might interest you: Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma, independent of the degree of airflow obstruction Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Once-daily tiotropium Respimat add-on therapy improves lung function and asthma control in moderate symptomatic asthma, independent of baseline characteristics Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007 Novel nebulisation of budesonide as add-on treatment in uncontrolled asthmatics Source: International Congress 2017 – Inhalers and their use Year: 2017 Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 High or standard initial dose of budesonide to control mild-to-moderate asthma? Source: Eur Respir J 2001; 17: 856-862 Year: 2001 Selenium add-on therapy in bronchial asthma patients Source: Eur Respir J 2007; 30: Suppl. 51, 614s Year: 2007 Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients Source: Eur Respir J, 53 (6) 1801824; 10.1183/13993003.01824-2018 Year: 2019 The effect of salmeterol/fluticasone on markers of airway inflammation in patients with uncontrolled asthma Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Ciclesonide improves measures of small airway involvement in asthma Source: Eur Respir J 2008; 31: 1213-1220 Year: 2008 Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010 Montelukast as add-on therapy in severe noninfectious COPD exacerbations Source: Eur Respir J 2003; 22: Suppl. 45, 241s Year: 2003 Ciclesonide is effective in the treatment of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001 Effects of add-on treatment with budesonide/formoterol combination in eosinophilic COPD patients Source: International Congress 2017 – Management of COPD Year: 2017